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Thomas J. Wandless
The three-dimensional structures of parts of two
enzymes that contain tandem Src homology 2 (SH2)
domains have recently been determined. The structures
suggest how the SH2 domains function in concert to
regulate enzymatic activity and localization.
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Phosphorylation is one of the most common currencies
used in the business of signal transduction. The interplay
between two classes of enzymes, kinases and phospha-
tases, controls the relative levels of the phosphorylated
species that are essential for many signaling processes [1].
The substrates of these enzymes include tyrosine, serine,
and threonine residues of proteins, as well as small
molecules such as phosphatidylinositol. Two factors
control the relative activities of kinases and phosphatases:
localization of the enzymes and direct modulation of their
catalytic activities [2]. The cellular signaling machinery, in
response to stimuli, is able to regulate the level of phos-
phorylation and so control the degree of protein–protein
association, required for intracellular signal transduction.
Such associations are often mediated by relatively small
protein subdomains that bind to specific proteins within
the signaling cascade [3].
Whether they are found as isolated domains of proteins or
attached to some catalytic machinery, Src homology 2
(SH2) and Src homology 3 (SH3) domains have become
hallmarks of proteins involved in intracellular signal trans-
duction (Fig. 1). SH2 domains bind tightly to phosphory-
lated tyrosine residues [4], and SH3 domains mediate
protein–protein interactions through recognition of spec-
ific proline-rich sequences [5]. Structural biologists
attacked these domains as soon as they were discovered,
and the wealth of three-dimensional information now
available includes ligand-bound as well as unbound struc-
tures for many SH2 and SH3 domains (see references
within [6] for SH2 domains and within [5] for SH3
domains). SH2 and SH3 domains are often found within
larger enzymes, but the complete structure of one of these
enzymes has yet to be elucidated. Studies have focused
instead on individual SH2 and SH3 domains. Recently,
two structures have been determined in which two SH2
domains are structurally intertwined [6,7]. In each of these
structures, the close associations between the two SH2
domains suggest how the phosphotyrosine-binding
domains might act in concert to regulate enzymatic activ-
ity. Together with kinetic analyses, these structures
provide a good opportunity for reassessing whether or not
SH2 domains function independently of each other and of
the catalytic domains to which they are often coupled.
Eck, Shoelson et al. [7] determined the three-dimensional
structure of the two SH2 domains that constitute the
amino-terminal regulatory domain of the protein tyrosine
phosphatase SH-PTP2 (Fig. 1); this phosphatase has been
implicated as a positive mediator of signal transduction
downstream of several growth factor receptors [8]. The
structure of the two SH2 domains (residues 1–225 of SH-
PTP2), each bound to an identical phosphotyrosine-
containing peptide, reveals that both domains have the
same general fold found in other SH2 domains. The two
sequences have 50 % identical amino acids, and their struc-
tures are nearly superimposable, including the extended 11
amino-acid phosphotyrosine-containing peptide ligand. A
short stretch of four amino acids (residues 107–110) links
the two domains, resulting in a considerable degree of
shared surface area at the interface of the two domains. In
an unexpected twist, there is a disulfide bond between
Cys104 of the amino-terminal SH2 domain and Cys174 of
the carboxy-terminal SH2 domain, and this bond is buried
at the interface of the two SH2 domains. Intracellular
proteins rarely have disulfide bonds because the cellular
environment is reducing in nature, and Eck, Shoelson and
colleagues took precautions to prevent oxidation during
crystallization (the buffer contained 10 mM dithiothreitol);
there is, as yet, no evidence that this disulfide bond is
present within the cellular environment.
The tandem SH2 domains in its amino-terminal region
have been shown to down-regulate the phosphatase activ-
ity of SH-PTP2 [9]. Truncation of the two SH2 domains
yields an isolated catalytic domain that has 55-fold higher
phosphatase activity than the full-length enzyme.
Although it has been difficult to identify the cellular
substrates of the phosphatase domain, cellular ligands of
the SH2 domains have been identified and include the
platelet-derived growth factor receptor (PDGFR) and the
insulin receptor substrate-1 (IRS-1). Two of the 32 possi-
ble phosphotyrosine-containing peptides from IRS-1 are
high-affinity ligands of the SH2 domains of SH-PTP2.
The phosphorylated IRS-1 peptides containing residues
pTyr1172 and pTyr1222 bind selectively to the amino-
terminal and carboxy-terminal SH2 domains, respectively
[9]. Alone or as an equimolar mixture, these peptides
moderately stimulate the phosphatase activity of SH-
PTP2, but full enzymatic activation (55-fold) is observed
only using two phosphotyrosine-containing peptides that
are covalently linked through an appropriately chosen
spacer element [10].
Enzymatic activation appears to be governed by the
geometry of the ligands for the SH2 domains, and Shoel-
son and coworkers [10] have explored this phenomenon
using two phosphotyrosine-containing peptides fused
through a series of covalent linkers. Kinetic studies of 
SH-PTP2 reveal that phosphatase activation, through
either removal or engagement of the SH2 domains,
involves a change in the rate-determining step along the
reaction coordinate pathway (T.J.W. and C.T. Walsh,
unpublished observations). This change is such that
engagement of the SH2 domains may initiate a rearrange-
ment of the regulatory domain relative to the catalytic
domain, resulting in phosphatase activation. The activated
phosphatase domain of full-length SH-PTP2 is kinetically
indistinguishable from the isolated phosphatase domain
obtained by removal of the  SH2 domains.
It appears that the two SH2 domains of SH-PTP2 have
been fused, functionally as well as structurally, to form a
larger enzyme-regulatory domain that is responsible for
direct modulation of catalytic activity as well as protein
localization. This regulatory role is dependent on engage-
ment of both SH2 domains by phosphotyrosine-containing
ligands of defined structure. This selective regulatory
mechanism might allow SH-PTP2 to function in more
than one capacity within multiple signaling cascades. For
example, upon activation of the PDGFR, the amino-
terminal SH2 domain of SH-PTP2 binds to a specific
phosphotyrosine within the PDGFR [11]. SH-PTP2 is
then phosphorylated on a tyrosine (pTyr542) located
immediately carboxy-terminal to the phosphatase domain.
This phosphotyrosine  serves as a binding site for the
adaptor protein Grb2, which is recruited to the membrane
and activates the Ras signaling pathway [11]. Within this
signaling cascade, SH-PTP2 functions as an adaptor, and
engagement of only the amino-terminal SH2 domain
might allow SH-PTP2 to fulfil its signaling role without
stimulation of phosphatase activity. In other circum-
stances, engagement of both SH2 domains by a protein
such as IRS-1 may liberate the repressed catalytic machin-
ery and allow SHPTP2 to participate in signaling path-
ways through dephosphorylation of phosphotyrosine-
containing substrates.
A similar regulatory domain composed of two SH2
domains has been found within the T-cell tyrosine kinase,
zeta-associated protein (ZAP-70). Upon T-cell activation,
several subunits of the T-cell receptor become tyrosine-
phosphorylated and ZAP-70, an essential component of
this signaling cascade, associates with the activated recep-
tor through its SH2 domains (Fig. 1) [12]. A group from
Ariad Pharmaceuticals [6] has determined the three-
dimensional structure of the ZAP-70 amino-terminal regu-
latory domain (residues 1–259) in a complex with a doubly
phosphorylated 19-residue phosphotyrosine-containing
peptide from the z-chain of the T-cell receptor. The SH2
domains display the now-familiar fold typical of the family
and are separated from each other by a 65-residue stretch
of two a-helices that form a coiled coil. The carboxy-
terminal SH2 domain binds to its cognate ligand through
interactions that are similar to those observed in SH-
PTP2–ligand and other SH2 domain–ligand complexes:
two pockets along the surface of the SH2 domain are occu-
pied by the phosphotyrosine side chain and the leucine
side chain in the (pTyr + 3) position. For the other SH2
domain a departure from the conventional binding motif is
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Figure 1
Four proteins involved in intracellular signal transduction that contain
SH2 or SH3 domains. The three-dimensional structure of Grb2 reveals
how one SH2 domain and two SH3 domains may be independently
arrayed to recognize their respective partner proteins [15]. The SH3
and SH2 domains of the Src-family protein tyrosine kinase, Lck, have a
closer structural relationship [16]. This interdependence is probably
shared by Src, in which both SH domains are required for
autoinhibition and recognition of an associated phosphoprotein, p68.
The regulatory domain of the protein tyrosine phosphatase SH-PTP2
contains two SH2 domains, and the SH2 domains found within ZAP-
70 are also closely associated with each other (see text). The exact
relationships between the regulatory domains shown here and their
respective catalytic domains remain unknown, as structures of the full-
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found: within the amino-terminal SH2 domain, a
hydrophobic pocket also accommodates the (pTyr + 3)
leucine, but the phosphotyrosine-binding pocket is sand-
wiched at the interface of the two SH2 domains (Fig. 1).
Stabilizing contacts to the phosphotyrosine side chain are
donated by both the amino-terminal and the carboxy-
terminal SH2 domains, providing a three-dimensional
explanation for the experimental observation that the
individual ZAP-70 SH2 domains do not bind to phospho-
tyrosine-containing peptide ligands [13].
The authors suggest [6] that the organization of the lig-
anded SH2 domains might exert allosteric effects on the
catalytic domain of ZAP-70. In support of this theory, the
closely related kinase Syk is stimulated upon engagement
of its SH2 domains by phosphotyrosine-containing
peptide ligands [14]. Unlike the covalently fused SH2
domains from SH-PTP2, the two SH2 domains from
ZAP-70 may not dimerize in the absence of phosphotyro-
sine-containing ligands. The X-ray structure reveals that
the two SH2 domains share a modest 200 Å2 of surface
area with each other, whereas the surface area buried
between regulatory domain and the extended peptide
ligand amounts to 1300 Å2, in a significantly stabilizing
interaction. Assembly of the regulatory SH2 domains is
assisted by the inter-domain coiled coil as well as by con-
tacts between the doubly phosphorylated peptide and the
SH2 domains. The tandem SH2 domains within SH-
PTP2, and those within ZAP-70, are sandwiched together
and provide a sensitive mechanism for the modulation 
of catalytic activity upon binding to phosphotyrosine-
containing peptides.
The structures of the SH-PTP2 and ZAP-70 regulatory
domains provide the first three-dimensional views of how
Src homology domains might regulate the enzymatic activ-
ities of catalytic domains with which they are associated
[6,7]. Within the regulatory domains, single SH2 domains
are not as independent as one might have predicted on the
basis of previous structures. But the picture is far from
complete in the absence of structural information relating
these regulatory domains to their respective catalytic
domains. Structural biology complements biochemical and
molecular genetic techniques as a powerful means of
elucidating mechanisms of signal transduction, and an
atomic-resolution understanding of the regulation of these
enzymes will aid efforts to manipulate signaling cascades
for therapeutic purposes. ZAP-70 appears to be a unique
component of the T-cell activation machinery, and
molecules that interfere with the association between
ZAP-70 and the z-chain of the T-cell receptor may prove
to be selective immunosuppressive agents. The SH2
domains within SH-PTP2 and ZAP-70 modulate the local-
ization and enzymatic activity of the catalytic domains to
which they are attached, and the structures of these
regulatory domains provide two distinct models of how
Nature might use more than one modular protein
subdomain to govern cellular signaling.
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